Clinical Trial Update: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities [NA]

View source ↗

Summary

A completed clinical trial evaluating mass drug administration with dihydroartemisinin-piperaquine and a single low-dose primaquine to accelerate malaria elimin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Primaquine (primaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria,Falciparum, Malaria | NA | Status: COMPLETED